VIP 500 mcg/mL — 5 mL
An intranasal form of VIP, a naturally occurring signaling peptide, for people on a clinician-guided, personalized wellness plan.
Rx only — requires provider review
Save $20.00
Strength
500 mcg/mL · 5 mLPurchase option
Not available in AR, IN, MN, SC — checkout enforces state eligibility.
VIP (vasoactive intestinal peptide) is a naturally occurring signaling peptide that interacts with receptors involved in immune regulation and other body systems. The nasal spray format is designed to deliver it across the tissues lining the nasal passages.
It is generally chosen by people working with a clinician on a personalized wellness plan who want a peptide-based option delivered intranasally. As with other longevity-oriented treatments, it is approached as one component of an individualized approach rather than a standalone answer.
This is a prescription treatment intended to be used under medical supervision. OpenDoseRx treatments are dispensed only after a licensed provider reviews your health intake and determines a prescription is appropriate for you.
How ordering works
Choose your strength
Pick the exact dose and pack size. You see the price before you commit — nothing is hidden until checkout.
A provider reviews your intake
Complete a short medical intake. An independent, licensed U.S. provider decides if it's appropriate — and if they decline, you're refunded in full.
Compounded and shipped
Approved orders are prepared by a licensed U.S. pharmacy and shipped discreetly to your door.
What VIP (vasoactive intestinal peptide) is: background on the neuropeptide
A plain-language, mechanism-focused look at the neuropeptide VIP — what it is, the receptors it acts on, and the signaling and immune roles studied in research.
NAD+ precursors: what NMN and NR are and how they work
A mechanism-focused look at NAD+ as a cellular coenzyme and how the precursors NMN and NR feed the salvage pathway that regenerates it.
How rapamycin (sirolimus) is understood to act on the mTOR pathway
A mechanism-focused overview of rapamycin (sirolimus), the mTOR signaling pathway, and why mTORC1 and autophagy are areas of research interest.
